SEL ICB Lambeth Community Denosumab Service
Estimated value
—
Awarded value
—
Suppliers
1
Lots
1
Published
28 Apr 2026
Description
Provision of a community-based shared care service for the administration and monitoring of denosumab 60mg/ml for osteoporosis. The service will support patients in Lambeth (or registered with a Lambeth GP) who have been identified by secondary care as clinically appropriate for treatment in the community. The Provider will deliver blood monitoring, prescribing support, and timely administration of injections in accordance with the South East London Shared Care Agreement, while clinical responsibility remains with secondary care.
Scope
- Reference
- ocds-h6vhtk-068c80
- Commercial tool
- Standalone contract
- Main category
- services
- CPV classifications
- 85141000
- Contract locations
- London
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Award Criteria: Cost & Quality criteria Cost & Quality criterion: the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard Weighting: 100% | 100% | cost | — |
Submission & procedure
- Procedure
- Award procedure without prior publication of a call for competition
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—